143 related articles for article (PubMed ID: 35498155)
1. FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance.
Wang Z; Sun BS; Chen ZS; Zhao KK; Wang YL; Meng FX; Zhang Y
Anal Cell Pathol (Amst); 2022; 2022():9675466. PubMed ID: 35498155
[TBL] [Abstract][Full Text] [Related]
2. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
Duan W; Liu X
Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
[TBL] [Abstract][Full Text] [Related]
3. FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth.
Jin R; Li H; Nan S; Wang H
Syst Biol Reprod Med; 2024 Dec; 70(1):113-123. PubMed ID: 38743820
[TBL] [Abstract][Full Text] [Related]
4. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
5. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
[TBL] [Abstract][Full Text] [Related]
6. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals.
Zhang XL; Wang HS; Liu N; Ge LC
Arch Biochem Biophys; 2015 Nov; 585():10-16. PubMed ID: 26363213
[TBL] [Abstract][Full Text] [Related]
7. MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.
Na XY; Shang XS; Zhao Y; Ren PP; Hu XQ
Neoplasma; 2019 Mar; 66(2):211-221. PubMed ID: 30509104
[TBL] [Abstract][Full Text] [Related]
8. FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients.
He S; Zhang J; Zhang W; Chen F; Luo R
J Exp Clin Cancer Res; 2017 Dec; 36(1):175. PubMed ID: 29208003
[TBL] [Abstract][Full Text] [Related]
9. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.
Liu H; Song M; Sun X; Zhang X; Miao H; Wang Y
Bioengineered; 2021 Dec; 12(1):565-577. PubMed ID: 33557670
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway.
Pan J; Xu Z; Xu M; Lin X; Lin B; Lin M
J Int Med Res; 2020 Dec; 48(12):300060520971453. PubMed ID: 33296605
[TBL] [Abstract][Full Text] [Related]
11. Forkhead-box A1 induces cell senescence in endometrial cancer by regulating p16INK4a.
Wang J; Bian Y; Liao Y; Xia Y; Wan X
Oncol Rep; 2016 Aug; 36(2):795-802. PubMed ID: 27349269
[TBL] [Abstract][Full Text] [Related]
12. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
14. NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation.
Yue M; Yun Z; Li S; Yan G; Kang Z
RNA Biol; 2021 Nov; 18(11):1981-1995. PubMed ID: 33530829
[TBL] [Abstract][Full Text] [Related]
15. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
17. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
18. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.
Tang DE; Dai Y; Xu Y; Lin LW; Liu DZ; Hong XP; Ou ML; Jiang HW; Xu SH
Carcinogenesis; 2020 Mar; 41(1):56-66. PubMed ID: 31046116
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
Fu X; Jeselsohn R; Pereira R; Hollingsworth EF; Creighton CJ; Li F; Shea M; Nardone A; De Angelis C; Heiser LM; Anur P; Wang N; Grasso CS; Spellman PT; Griffith OL; Tsimelzon A; Gutierrez C; Huang S; Edwards DP; Trivedi MV; Rimawi MF; Lopez-Terrada D; Hilsenbeck SG; Gray JW; Brown M; Osborne CK; Schiff R
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6600-E6609. PubMed ID: 27791031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]